Viewing Study NCT07454668


Ignite Creation Date: 2026-03-26 @ 3:15 PM
Ignite Modification Date: 2026-03-30 @ 2:16 AM
Study NCT ID: NCT07454668
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-06
First Post: 2026-02-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
Sponsor: Baptist Health South Florida
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module